Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-05-19

Clinical Trial Update: Effect of Eslicarbazepine Acetate on the Pharmacokinetics of Gliclazide in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the effect of eslicarbazepine acetate on the pharmacokinetics of gliclazide in healthy volunteers to assess potential drug–drug interac…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Gliclazide (gliclazide)
  • eslicarbazepine acetate (eslicarbazepine acetate)

Snippet

Sponsor: Bial - Portela C S.A. | Conditions: Epilepsy | Phase 1 | Status: COMPLETED